Overview

Ultrasound Evaluation of Crohn's Disease

Status:
Terminated
Trial end date:
2021-10-12
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess the effectiveness of a new ultrasound technology for evaluating Crohn's disease.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mayo Clinic
Criteria
Inclusion Criteria:

- Crohn's disease patients with involvement of terminal ileum (thickness > 3mm).

Exclusion Criteria:

- Patients with change of medicine or going to surgery over the 6-months follow-up
period.

- Patients with unreliable ultrasound images due to conditions such as large body
habitus or poor ultrasound imaging window.

- Adults lacking capacity to consent.

- Vulnerable subjects such as prisoners.

- Pregnant women and nursing mothers.

- Patients with known or suspected right-to-left, bi-directional, or transient
right-to-left cardiac shunts.

- Patients with history of hypersensitivity allergic reactions to ultrasound contrast
agents.